Brief: Wntresearch Delays Start Of Phase 2 Study With Foxy-5

Opsy Holding AB

13/02/2018 07:15

Feb 13 (Reuters) - WNTRESEARCH AB  WNT.TE : 
    * WNTRESEARCH DELAYS START OF PHASE 2 STUDY WITH FOXY-5 
    * NO DOSE TITRATION OF FOXY-5 WILL BE NECESSARY, AS 
CO-TREATMENT 
WITH FOLFOX IS NO LONGER PLANNED IN STUDY 
 
Source text for Eikon:  ID:nWkr6SwzxW  
Further company coverage:  WNT.TE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))